All data is delayed
See More

Drug firms win R2.5bn tender

Aug 07 2012 08:05

Company Data


Last traded 289
Change 3
% Change 1
Cumulative volume 1816191
Market cap 0

Last Updated: 02-10-2015 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA


Last traded 50
Change 0
% Change 1
Cumulative volume 58448
Market cap 0

Last Updated: 02-10-2015 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen prepared to help bridge ARV shortages

Aspen lifts H1 profit, Asia unit flies

Aspen buys GSK brands

Adcock buys Indian medicine business

Adcock eyes higher earnings

Loss of high margin drugs hits Adcock


Johannesburg - The first tender aligned with government's latest industrial policy has been awarded by the department of health, Business Day reported on Tuesday.

The R2.55bn oral solids tender was won by Aspen Pharmacare Holdings [JSE:APN] and Adcock Ingram Holdings [JSE:AIP].

Aspen received R634m of the tender while Adcock secured R270m of it.

This is the second biggest medicines contract after HIV/Aids drugs.

The new industrial policy has designated the pharmaceutical sector as one in which local manufacturers should be given preference to boost business in South Africa.



Read Fin24’s Comments Policy publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

We're talking about:


With infrastructure spending having been identified as one of the key focus areas of the National Development Plan, tradesmen will continue to play a critical role in growing the South African economy through their skills..

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

A 30% a month return on investment is:

Previous results · Suggest a vote